Top Buy
| Security | Buy | Sell ▼ | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sangamo Therapeutics Inc. | 13 | 17 | 1 | 5 | €0.85 | €4.10 | 383.850% |
| PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | €30.40 | €41.46 | 36.391% |
| Affimed N.V. | 12 | 6 | 0 | 0 | €0.55 | €6.61 | 1095.570% |
| Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | €46.11 | €56.86 | 23.318% |
| Pfizer Inc. | 28 | 4 | 1 | 0 | €28.47 | €41.47 | 45.669% |
| Enanta Pharmaceuticals Inc. | 6 | 4 | 0 | 0 | €13.90 | €25.58 | 84.014% |
| Omeros Corp. | 2 | 4 | 0 | 0 | €4.73 | - | - |
| Immunic Inc. | 5 | 3 | 1 | 0 | €1.34 | €6.61 | 393.450% |
| Fate Therapeutics Inc. | 4 | 3 | 1 | 0 | €5.04 | €7.31 | 45.048% |
| Bayer AG | 15 | 3 | 2 | 2 | €27.43 | €45.00 | 64.084% |
| Emergent Biosolutions Inc. | 4 | 3 | 1 | 0 | €13.44 | - | - |
| Phibro Animal Health Corp. A | 3 | 2 | 0 | 0 | €17.20 | €12.06 | -29.860% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 0 | 0 | €8.37 | €26.25 | 213.576% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 4 | 0 | €26.67 | €54.98 | 106.153% |
| Akebia Therapeutics Inc. | 7 | 2 | 0 | 0 | €1.35 | €3.64 | 169.956% |
| ProQR Therapeutics N.V. | 8 | 2 | 0 | 0 | €1.71 | €3.03 | 77.971% |
| TG Therapeutics Inc. | 21 | 2 | 0 | 0 | €18.46 | €28.06 | 52.062% |
| Vertex Pharmaceuticals Inc. | 55 | 2 | 4 | 0 | €460.80 | €450.36 | -2.265% |
| Roche Holding AG ADR | 3 | 2 | 1 | 0 | €37.46 | €38.00 | 1.454% |
| Incyte Corp. | 13 | 2 | 1 | 1 | €63.46 | €77.67 | 22.394% |
| Alkermes plc | 17 | 2 | 3 | 0 | €26.40 | €35.01 | 32.626% |
| Merck KGaA | 3 | 2 | 0 | 1 | €164.35 | €146.00 | -11.165% |
| Gilead Sciences Inc | 11 | 1 | 1 | 0 | €71.60 | €85.27 | 19.098% |
| NanoViricides Inc. | 1 | 1 | 1 | 0 | €1.96 | €3.00 | 53.061% |
| G1 Therapeutics | 21 | 1 | 0 | 0 | €3.35 | €10.54 | 214.541% |